Menzel Garry E
- SEC CIK
- 0001556064
No open-market purchases or sales filed in the past year.
Current role at each company
- BDTX Black Diamond Therapeutics, Inc.Directoras of Jun 29, 2026
- STOK Stoke Therapeutics, Inc.Directoras of Jun 4, 2025
- ADAPY Adaptimmune Therapeutics PLCDirectoras of Jul 1, 2024
- TCRR TCR2 Therapeutics Inc.President and CEOas of Jun 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Menzel Garry E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADAPY Adaptimmune Therapeutics PLC
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 (view filing) | Jul 10 | Same day | Menzel Garry EDirector | SSaleAmerican Depositary Shares representing Ordinary Shares | −47.7K | $0.91 | −$43.4K | −38.9%75.1K after |
TCRR TCR2 Therapeutics Inc.
President and CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 (view filing) | Dec 9-13 | 4 days | Menzel Garry EPresident and CEO | SSale | −31.9K | $1.10 | −$35.0K | −18.7%138.9K after | 3 lots |
| Dec 9, 2022 (view filing) | Dec 7-8 | 2 days | Menzel Garry EPresident and CEO | SSale | −18.4K | $1.26 | −$23.3K | −9.7%170.8K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5-6 | 2 days | Menzel Garry EPresident and CEO | SSale | −23.4K | $1.36 | −$31.8K | −11.0%189.2K after | 2 lots |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Menzel Garry EPresident & CEO | SSale | −8.41K | $1.39 | −$11.7K | −3.8%212.7K after |